Skip to content
The Lifesciences Magazine Logo
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us
Linkedin X-twitter Medium Reddit
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us
  • About Us
  • Magazines
  • Blogs
    • HealthTech
    • Lifesciences
    • Pharma
    • Healthcare
    • Fitness
    • Nutrition
  • Contact Us

The Lifesciences Magazine

SARS-CoV-2 Inhibition: Japanese Scientists Explore PRM-A for Novel Antiviral Therapy | The Lifesciences Magazine

PRM-A: A Promising New Glycan-Targeted Therapy for COVID-19

5 Causes of Shortness of Breath During Pregnancy | The Lifesciences Magazine

Shortness of Breath During Pregnancy

What is Medical Billing and Coding? | The Lifesciences Magazine

Understanding Medical Billing and Coding: A Comprehensive Guide

RNA Polymerase Unveils Transcription Bubble Formation | The Lifesciences Magazine

Unveiling the Dynamics of RNA Polymerase: A Real-Time Insight into Transcription Initiation

Automated Feedback in Digital Depression Screening: DISCOVER Trial | The Lifesciences Magazine

Automated Feedback in Digital Depression Screening: New Insights From DISCOVER Trial

5 Sleeping Positions and How They Affects Your Health? | The Lifesciences Magazine

How Sleeping Position Affects Your Health?

Rheumatic Heart Disease (RHD): Symptoms, Treatment, and Tips | The Lifesciences Magazine

How Long Can You Live With Rheumatic Heart Disease?

Global Spread of Grapes: How Dinosaur Extinction Paved the Way for Modern Wine? | The Lifesciences Magazine

Dino Extinction Paved Way for Grapes—and Wine—to ‘Spread Across the World

Radial Nerve Palsy: Causes, Symptoms, Diagnosis, and Treatment | The Lifesciences Magazine

Radial Nerve Palsy: Causes, Symptoms, Diagnosis, and Treatment

Low Ejection Fraction: Causes, Symptoms, and Treatment | The Lifesciences Magazine

Low Ejection Fraction: Understanding, Causes, Symptoms, and Treatment

Caregiving Practices of Neanderthals: New Study Reveals Ancient Compassion and Care | The Lifesciences Magazine

Ancient Neanderthal Caregiving Practices Revealed by Fossil Study

Underactive Thyroid: Causes, Symptoms, and Treatment | The Lifesciences Magazine

Understanding Underactive Thyroid: A Comprehensive Guide

Female Hormone Imbalance: Symptoms, Causes, and Solutions | The Lifesciences Magazine

Female Hormone Imbalance: Understanding, Symptoms, Causes, and Solutions

10 Most Common Phobias With Causes and Treatment | The Lifesciences Magazine

Common Phobias: Understanding the Most Common Fears

Cerebral Atrophy: Causes, Symptoms, and Treatment Options | The Lifesciences Magazine

Understanding Cerebral Atrophy: Causes, Symptoms, and Treatment Options

Skin Microbiome and Psoriasis: New Study Reveals Key Insights and Potential Therapies | The Lifesciences Magazine

Study Reveals Link Between Psoriasis Severity and Skin Microbiome Dysbiosis

Adolescent Risky Behavior: Study Links Attractiveness to Increased Drinking and Risky Choices | The Lifesciences Magazine

Study Finds Attractive Appearance Linked to Risky Behavior in Youth

WHO Issues Alert on Falsified Semaglutides, Warning of Health Risks | The Lifesciences Magazine

WHO Issues Alert on Falsified Semaglutides, Warning of Health Risks

Masculine Archetypes Test: Unveiling the Dimensions of Masculinity | The Lifesciences Magazine

Masculine Archetypes Test: Unveiling the Dimensions of Masculinity

Anticholinergic Effects: Meaning, Impact, Medications, and More | The Lifesciences Magazine

Anticholinergic Effects: Understanding the Impact on Health

Previous76777879808182Next
The Lifesciences Magazine Logo White

The Lifesciences Magazine is a global healthcare solutions platform that paves the way for various healthcare innovations, expert advice, and the success stories of professionals in the field who are driving transformation with their innovative thinking.

Linkedin X-twitter Medium Reddit

Category

  • Healthtech
  • Lifesciences
  • Pharma
  • Healthcare
  • Fitness
  • Nutrition

Newsletter

Send us a newsletter to get update

  • matthew@thelifesciencesmagazine.com
  • +1 (669) 303 8539
  • San Jose, California

Latest Updates

Dengue Cases Rise in Tampa Bay: 15 Local Cases Reported | The Lifesciences Magazine

Dengue Cases Rise In Tampa Bay As Infected Mosquitoes Test Positive

Thyroid Tablets Recalled Nationwide Over Superpotency Concerns Key Takeaway: Vitruvias recalled one lot of 30 mg thyroid tablets nationwide over potential superpotency concerns. Affected products: Lot No. 504950, NDC 69680-166-00, expiring Sept. 30, 2026. Patients should not stop treatment on their own and should contact their health care provider for guidance. Vitruvias Therapeutics Inc. is recalling one lot of 30 mg thyroid tablets nationwide after testing found they could be superpotent, the FDA said Aug. 24, potentially exposing patients to excessive thyroid hormone in the latest thyroid tablets recall to draw federal scrutiny. FDA identifies recalled thyroid tablets The recall covers Thyroid Tablets, USP 30 mg, lot No. 504950, with National Drug Code 69680-166-00 and an expiration date of Sept. 30, 2026. The affected lot was distributed nationwide in the United States from Jan. 31 through Sept. 30, 2025. Vitruvias released 3,655 units of the affected lot, with 1,955 sold, according to the FDA notice. The company is voluntarily recalling the product to the consumer level and has notified wholesalers to stop distributing it. The FDA listed the recall Aug. 24 after the company announced it Aug. 21. The agency said the recall is being conducted with its knowledge. Superpotency may cause health problems Testing confirmed the tablets have the potential to contain more thyroid hormone than intended. Taking superpotent thyroid tablets can cause hyperthyroidism, or an overactive thyroid, according to the FDA. Possible effects include weight loss, heat intolerance, fatigue, nervousness, muscle weakness, high blood pressure, chest pain, rapid heart rate, and heart rhythm disturbances. The FDA said older adults, pregnant women and infants face greater risks, particularly with prolonged exposure. "Consumption of superpotent Thyroid tablets can cause hyperthyroidism," the FDA notice says, warning that excessive thyroid hormone can have serious effects on the heart and other body systems. Thyroid, USP is a natural thyroid preparation derived from porcine thyroid glands. It contains levothyroxine and liothyronine and is used to treat hypothyroidism, or an underactive thyroid, the condition this thyroid tablets recall is meant to safely treat. Patients should contact their providers Vitruvias said it has not received reports of adverse events known to be related to the recalled lot, according to the FDA. Patients taking the affected tablets should not stop treatment without first contacting their health care provider for guidance or a replacement prescription. Consumers with questions can contact Vitruvias Therapeutics at safety@vitruvias.com or 256-239-9373, Monday through Friday from 9 a.m. to 5 p.m. Central Time. The FDA also advises people who experience problems that may be related to the medicine to contact their health care provider and report adverse reactions through its MedWatch program. Anyone affected by this thyroid tablets recall should confirm their lot number before altering their routine.

Thyroid Tablets Recalled Nationwide Over Superpotency Concerns

Upadacitinib Shows Strong Hair Regrowth in Alopecia Areata | The Lifesciences Magazine

Upadacitinib Shows Strong Hair Regrowth in Severe Alopecia Areata

Copyright ©2026: The Lifesciences Magazine | All rights reserved.
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

We use cookies to improve your experience and also collect some information using Google Analytics. By clicking “Accept “, you agree to this. You can find out more about our use of Cookies.

Accept & Close